Search Results - "Haythe, J"

Sex Differences in Characteristics and Outcomes Following HeartMate 3 Left Ventricular Assist Device Implantation by DeFilippis, E., Haythe, J., Marshall, D., Lin, E., Axsom, K., Truby, L., Yuzefpolskaya, M., Colombo, P., Sayer, G., Takayama, H., Takeda, K., Naka, Y., Farr, M., Uriel, N., Topkara, V.K.

“…In addition to goal-directed therapies, advanced therapies for heart failure including left ventricular assist devices (LVADs) remain underutilized in women…”
Get full text

Utilization of Mechanical Circulatory Support Devices and Impact on Outcomes in the New Heart Allocation System: An Analysis of the UNOS Registry by Truby, L.K., Farr, M., Defillipis, E., Takeda, K., Takayama, H., Colombo, P.C., Yuzefpolskaya, M., Haythe, J., Axsom, K.M., Naka, Y., Uriel, N., Topkara, V.K.

“…In October 2018, a new heart transplantation (HT) allocation system was implemented with the intent of prioritizing the most medically urgent candidates,…”
Get full text

C-reactive Protein Levels Predict Right Ventricular Failure and Mortality in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Assist Device Implantation: An INTERMACS Analysis by Batra, J., Truby, L., Garan, R., Haythe, J., Lin, E., Axsom, K., Yuzefpolskaya, M., Colombo, P., Sayer, G., Takayama, H., Takeda, K., Naka, Y., Farr, M., Uriel, N., Topkara, V.K.

“…Whether C-reactive protein (CRP) levels prior to left ventricular assist device implantation (LVAD) are predictive of post-implantation outcomes is not well…”
Get full text

Impact of Heart Failure Drug Therapy on GI Bleeding Rates in LVAD Recipients: An INTERMACS Analysis by Jennings, D.L., Truby, L., Fried, J., Clerkin, K., Griffin, J., Raikhelkar, J., Axsom, K., Lin, E., Haythe, J., Yuzefpolskaya, M., Colombo, P., Sayer, G., Farr, M., Takayama, H., Takeda, K., Naka, Y., Uriel, N., Topkara, V.K.

“…Gastrointestinal bleeding (GIB) remains a common and vexing complication of left ventricular assist device (LVAD) support. Recent single-center analyses…”
Get full text

HeartMate II Risk Score (HMRS) and MELD-Xi Scores Do Not Predict Mortality in HeartMate 3 LVAD Patients by Marshall, D., Truby, L., DeFilippis, E., Malick, A., Butler, C., Masoumi, A., Haythe, J., Axsom, K., Lin, E., Yuzefpolskaya, M., Colombo, P., Sayer, G., Takayama, H., Takeda, K., Naka, Y., Farr, M., Uriel, N., Topkara, V.K.

“…Heartmate II risk score (HMRS) and MELD-Xi score are validated mortality risk predictors in Heartmate II left ventricular assist device (LVAD) patients…”
Get full text

Bridging to Transplantation with Contemporary Continuous-Flow Left Ventricular Assist Devices: A Decade Experience by Truby, L.K, Givens, R, Garan, A.R, Yuzefpolskaya, M, Flannery, M, Takayama, H, Takeda, K, Haythe, J, Latif, F, Restaino, S, Maurer, M, Mancini, D.M, Naka, Y, Farr, M, Colombo, P.C, Topkara, V.K

Get full text

Effects of Hospital Characteristics on In-Hospital Mortality and Hospitalization Costs for Mechanical Circulatory Support Device (MCSD) Therapy: Results from the National (Nationwide) Inpatient Sample (NIS) by Sridharan, L, Givens, R, Garan, A.R, Yuzefpolskaya, M, Takeda, K, Latif, F, Restaino, S, Haythe, J, Maurer, M, Mancini, D.M, Farr, M, Naka, Y, Colombo, P.C, Topkara, V

Get full text

Mechanical Circulatory Support Devices (MSCD) Therapy in the Era of the Affordable Care Act (ACA): National Trends in Hospitalization Costs and In-Hospital Mortality by Sridharan, L, Givens, R, Garan, A.R, Yuzefpolskaya, M, Takeda, K, Takayama, H, Latif, F, Haythe, J, Restaino, S, Maurer, M, Mancini, D, Farr, M.J, Naka, Y, Colombo, P, Topkara, V.K

Get full text

The New Heart Allocation System: Implications on Patients with Restrictive Cardiomyopathy in the UNOS Registry by Sridharan, L, Givens, R, Takeda, K, Garan, A.R, Yuzefpolskaya, M, Latif, F, Restaino, S, Haythe, J, Ginns, J, Mancini, D, Naka, Y, Colombo, P, Maurer, M, Takayama, H, Topkara, V.K

Get full text

Red Cell Distribution Width Predicts 1-Year Mortality Following Heart Transplantation by Truby, L.K, Garan, A.R, Givens, R, Takayama, H, Takeda, K, Haythe, J, Yuzefpolskaya, M, Latif, F, Restaino, S, Zorn, E, Mancini, D, Naka, Y, Colombo, P.C, Farr, M, Topkara, V.K

Get full text

Changes in Lipid Profile Subfractions on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Therapy by Topkara, V.K, Garan, A.R, Yuzefpolskaya, M, Takeda, K, Takayama, H, Fried, J.A, Wong, K, Jennings, D, Te-Frey, R, Haythe, J, Maurer, M, Farr, M.A, Mancini, D.M, Naka, Y, Colombo, P.C

Get full text

Prospective Evaluation of Urine Dipstick for Detection of Significant Hemolysis in Outpatients on CF-LVAD Support by Gavalas, M, Breskin, A, Eisenberger, A.B, Yuzefpolskaya, M, Garan, A.R, Castagna, F, Wong, K, Tiburcio, M, Te-Frey, R, Haythe, J, Mancini, D.M, Takayama, H, Takeda, K, Naka, Y, Topkara, V.K, Colombo, P.C

Get full text

Lactate Dehydrogenase Isoenzyme Monitoring in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) by Topkara, V.K, Garan, A.R, Yuzefpolskaya, M, Takeda, K, Takayama, H, Cagliostro, B, Effner, L, Castagna, F, Singh, S, Fried, J.A, Haythe, J, Maurer, M, Farr, M.A, Mancini, D.M, Naka, Y, Colombo, P.C

Get full text

Risk of Post-Transplant Renal Dysfunction Is Increased in Patients Supported with Continuous-Flow Left Ventricular Assist Devices by Topkara, V.K, Trinh, P.N, Masoumi, A, Garan, A.R, Yuzefpolskaya, M, Takeda, K, Takayama, H, Haythe, J, Maurer, M, Latif, F, Restaino, S, Farr, M.A, Mancini, D.M, Naka, Y, Colombo, P.C

Get full text

Impact of Socioeconomic Status on Bridging with Contemporary Left Ventricular Assist Device (LVAD): Analysis of the UNOS Registry by Topkara, V.K, Wayda, B.J, Rao, S.D, Garan, A.R, Yuzefpolskaya, M, Takeda, K, Takayama, H, Castagna, F, Clemons, A.M, Wong, K, Trinh, P.N, Restaino, S, Latif, F, Haythe, J, Farr, M.A, Maurer, M, Mancini, D.M, Naka, Y, Colombo, P.C

Get full text

Increasing Use of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation by Clerkin, K.J, Thomas, S.S, Haythe, J, Schulze, P.C, Farr, M, Takayama, H, Jorde, U.P, Uriel, N, Restaino, S.W, Naka, Y, Mancini, D.M

Get full text

Safety of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation by Thomas, S.S, Clerkin, K.J, Haythe, J, Schulze, P.C, Farr, M, Takayama, H, Jorde, U.P, Uriel, N, Restaino, S.W, Naka, Y, Mancini, D.M

Get full text

217 Risk-Stratification of Heart Transplant (HTX) Candidates with Advanced Liver Dysfunction by Farr, M, Urtusan-Sotil, E, Kato, T, Schulze, P.C, Gukasyan, N, Uriel, N, Haythe, J, Bijou, R, Restaino, S, Jorde, U, Takayama, H, Brown, R, Emond, J, Naka, Y, Mancini, D

Get full text

Behcet's Disease Unmasked after Heart Transplantation by Bell, J., Takeda, K., Haythe, J., Szabolcs, M., Griffin, J., Geskin, L., Fanek, T., Gaine, M., Axsom, K.

“…Behcet's disease (BD) is an autoinflammatory, multisystem vasculitis. Cardiac involvement is rare and clinical diagnosis is challenging. We present a case of…”
Get full text

Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer by VAHDAT, L. T, BALMACEDA, C, HAYTHE, J, TROXEL, A, ANTMAN, K, HESDORFFER, C. S, PAPADOPOULOS, K, FREDERICK, D, DONOVAN, D, SHARPE, E, KAUFMAN, E, SAVAGE, D, TIERSTEN, A, NICHOLS, G

“…A single high-dose cycle of chemotherapy can produce response rates in excess of 50%. However, disease-free survival (DFS) is 15-20% at 5 years. The single…”
Get full text